Drug safety watch: tracking side effects of COVID-19 treatment in japan
NCT ID NCT05687877
Summary
This study monitored the safety of Evusheld, a drug used to treat and prevent symptomatic COVID-19, in real-world Japanese patients. Researchers tracked side effects in 366 people who received the drug as part of their regular medical care after it was approved for use. The goal was to understand how safe the drug is when used outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Aichi, Japan
-
Research Site
Chiba, Japan
-
Research Site
Fukuoka, Japan
-
Research Site
Fukushima, Japan
-
Research Site
Hiroshima, Japan
-
Research Site
Hokkaido, Japan
-
Research Site
Hyōgo, Japan
-
Research Site
Ibaraki, Japan
-
Research Site
Ishikawa, Japan
-
Research Site
Kagoshima, Japan
-
Research Site
Kanagawa, Japan
-
Research Site
Kyoto, Japan
-
Research Site
Mie, Japan
-
Research Site
Nara, Japan
-
Research Site
Numakunai, Japan
-
Research Site
Osaka, Japan
-
Research Site
Tokyo, Japan
-
Research Site
Tottori, Japan
Conditions
Explore the condition pages connected to this study.